Eli Lilly's valuation has been driven higher by investor excitement around GLP-1 drugs, leaving other drugmakers languishing.

The latest update to the Merck stock story centers on a revised price target, reflecting how analysts are reassessing the ...

Here are two options investors should consider: Johnson & Johnson ( JNJ 0.09%) and Merck ( MRK 1.54%). These two healthcare ...

​Guardant Health, Inc. (NASDAQ:GH) is one of the Best Russell 2000 Stocks to Buy Right Now. Wall Street has a positive ...

Plotting a challenge to Regeneron’s blockbuster Eylea, Ocular Therapeutix has hired “a key architect” of its rival’s launch ...

A routine jab for older adults may hold clues to healthier ageing—but experts say more proof is needed.

This symposium took place during the European Society for Medical Oncology (ESMO) Congress 2025 in Berlin, Germany. The aim ...

Defendazole is the first FDA-approved generic equivalent to Safe-Guard, a brand-name anthelmintic first approved for cattle and goats in 1994. 1 According to the FDA, the generic formulation was ...

The FDA has approved nixiFLOR, the first generic florfenicol-flunixin injectable, for treatment of bovine respiratory disease and control of associated fever in beef and nonlactating dairy cattle.

The label on the pill bottles found in warehouses in nine states said Biktarvy or Descovy, both antiviral HIV medications ...

The PTFE Membrane Market is poised for growth due to rising pharmaceutical demands and stricter water treatment regulations. Opportunities lie in expanding applications in biopharma, wastewater ...

Regeneron Pharmaceuticals, Inc. nears a key earnings report after a strong JPM Healthcare update. Click here to find out why ...